Connection

NORM LEHMAN to Tumor Suppressor Proteins

This is a "connection" page, showing publications NORM LEHMAN has written about Tumor Suppressor Proteins.
Connection Strength

1.188
  1. Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. J Neurooncol. 2019 Jun; 143(2):231-240.
    View in: PubMed
    Score: 0.513
  2. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun. 2019 03 15; 7(1):42.
    View in: PubMed
    Score: 0.509
  3. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. J Neurooncol. 2023 Feb; 161(3):425-439.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.